What are investors and partners looking for today (“How to Stand Out/Inflect Value in a Frothy Vat of Cells”)

Advanced Therapeutics
Wednesday, May 6, 2020 | 1:30 – 2:45 pm


  • John Bishai, VP, Healthcare Investment Banking, Wells Fargo Securities


  • John Delyani, PhD, MBA, VP Corporate Development, Tmunity Therapeutics Inc
  • Stanley Frankel, MD, SVP, Cellular Therapy, Celgene
  • Lee Greenberger, MD, PhD, SVP & CSO, Leukemia & Lymphoma Society
  • Michael Kalos, PhD, EVP and Head of R&D, Arsenal Biosciences
  • Michael G. King Jr., Entrepreneur in Residence, Fortress Biotech Inc.
  • Sharon Rooney-Mayer, Executive Director, Global Disease Strategy Lead Cell and Gene Therapies, Novartis Oncology
  • Mark Simon, Partner and Co-Founder, Torreya